NCT07541417 Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based Practices
| NCT ID | NCT07541417 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Prisma Health-Upstate |
| Condition | Opioid Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 750 participants |
| Start Date | 2026-04-08 |
| Primary Completion | 2029-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 750 participants in total. It began in 2026-04-08 with a primary completion date of 2029-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will provide longitudinal data for 6-months on a target sample of patients with Opioid Use Disorder (OUD) recruited from Prisma Health Mobile Health Clinics in South Carolina. The goal of our study is to increase OUD treatment initiation and retention and maximize prevention of overdose deaths in underserved communities through development, testing, and delivery of a novel intervention targeting areas of optimal allocation of MHC with a Peer Support Specialist (PSS) intervention.
Eligibility Criteria
Inclusion Criteria: * Age 18+ * Have diagnosis of OUD * New mobile health MOUD patient Exclusion Criteria: * Unable to read and comprehend the consent materials and other study materials * Currently working with a Certified Peer Support Specialist * Having severe medical or psychiatric disability that would hinder participation in the study, as determined by the clinical provider
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07541417 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07541417 currently recruiting?
Yes, NCT07541417 is actively recruiting participants. Contact the research team at ashley.king3@prismahealth.org for enrollment information.
Where is the NCT07541417 trial being conducted?
This trial is being conducted at Greenville, United States.
Who is sponsoring the NCT07541417 clinical trial?
NCT07541417 is sponsored by Prisma Health-Upstate. The trial plans to enroll 750 participants.